search
Back to results

Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG) (OLIDIAG)

Primary Purpose

Gestational Diabetes

Status
Recruiting
Phase
Not Applicable
Locations
Argentina
Study Type
Interventional
Intervention
Extra Virgin Olive Oil Addition
Sponsored by
Center for Pharmacological and Botanical Research
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Gestational Diabetes focused on measuring GDM, Extra Virgin Olive Oil, lipid profile, insulin requirement, postpartum reclassification

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • GDM (diagnosis criteria of the Latin American Society of Diabetes (ALAD) and Argentine Society of Diabetes (SAD): Fasting plasma glucosa > 100 mg/dl, p75 oral glucose tolerance test-2 h plasma glucose > 140 mg/dl)

Exclusion Criteria:

  • Multiple pregnancy
  • Pregestational diabetes (type 1 or type 2)
  • Bariatric surgery
  • Infectious diseases

Sites / Locations

  • Unidad Patagonica de Medicina Maternofetal y Embarazo de Alto RiesgoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Dietary addition of extra virgin olive oil

No addition of extra virgin Olive Oil

Arm Description

WHO diet with a daily addition of extra virgin olive oil

WHO diet

Outcomes

Primary Outcome Measures

maternal triglyceridemia
triglycerides in mg/dl
maternal weight gain
gestational maternal weight gain in kg
number of participants with insulin requirement
insulin use

Secondary Outcome Measures

number of participants with diabetes at postpartum
maternal diagnosis of diabetes at postpartum

Full Information

First Posted
October 14, 2021
Last Updated
September 15, 2023
Sponsor
Center for Pharmacological and Botanical Research
Collaborators
Sociedad Argentina de Diabetes
search

1. Study Identification

Unique Protocol Identification Number
NCT05120388
Brief Title
Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)
Acronym
OLIDIAG
Official Title
Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 11, 2022 (Actual)
Primary Completion Date
April 15, 2024 (Anticipated)
Study Completion Date
December 15, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Center for Pharmacological and Botanical Research
Collaborators
Sociedad Argentina de Diabetes

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Gestational diabetes mellitus (GDM) is associated to adverse maternal and neonatal outcomes. The aim of this study is to address whether the addition of extra virgin olive oil to the diet of women with GDM improves maternal triglyceridemia and reduces insulin requirement and diagnosis of diabetes at postnatal reclassification.
Detailed Description
This study is a randomized trial in which 1200 pregnant women at GDM diagnosis from 16 health care centers will be recruited and randomized in two parallel arms: 1 World Health Organization (WHO)-diet supplemented with 3 tablespoons of Extra Virgin Olive Oil (Intervention Group, n=600); 2. WHO-diet with no Extra Virgin Olive Oil supplementation (Control Group, n=600). Expected results: the investigators expect that the intervention will contribute to improve maternal lipid profile, reduce insulin requirement and reduce maternal diagnosis of diabetes at postpartum reclassification. Thus, this study is expected to identify maternal beneficial effects of this dietary intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes
Keywords
GDM, Extra Virgin Olive Oil, lipid profile, insulin requirement, postpartum reclassification

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Dietary intervention study: GDM patients receiving a WHO diet with or without addition of extra virgin olive oil
Masking
Investigator
Masking Description
Data analysis will be masked
Allocation
Randomized
Enrollment
1200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Dietary addition of extra virgin olive oil
Arm Type
Experimental
Arm Description
WHO diet with a daily addition of extra virgin olive oil
Arm Title
No addition of extra virgin Olive Oil
Arm Type
No Intervention
Arm Description
WHO diet
Intervention Type
Dietary Supplement
Intervention Name(s)
Extra Virgin Olive Oil Addition
Intervention Description
Daily dietary addition of olive oil (three tablespoons)
Primary Outcome Measure Information:
Title
maternal triglyceridemia
Description
triglycerides in mg/dl
Time Frame
term pregnancy
Title
maternal weight gain
Description
gestational maternal weight gain in kg
Time Frame
change from prepregnancy weight to term pregnancy weight
Title
number of participants with insulin requirement
Description
insulin use
Time Frame
term pregnancy
Secondary Outcome Measure Information:
Title
number of participants with diabetes at postpartum
Description
maternal diagnosis of diabetes at postpartum
Time Frame
six weeks postpartum

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: GDM (diagnosis criteria of the Latin American Society of Diabetes (ALAD) and Argentine Society of Diabetes (SAD): Fasting plasma glucosa > 100 mg/dl, p75 oral glucose tolerance test-2 h plasma glucose > 140 mg/dl) Exclusion Criteria: Multiple pregnancy Pregestational diabetes (type 1 or type 2) Bariatric surgery Infectious diseases
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alicia Jawerbaum, PhD
Phone
+541152853605
Email
a.jawerbaum@gmail.com
Facility Information:
Facility Name
Unidad Patagonica de Medicina Maternofetal y Embarazo de Alto Riesgo
City
Neuquén
State/Province
Neuquen
ZIP/Postal Code
Q8300BCI
Country
Argentina
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alicia Jawerbaum, PhD
Phone
+541152853605
Email
a.jawerbaum@gmail.com

12. IPD Sharing Statement

Learn more about this trial

Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG)

We'll reach out to this number within 24 hrs